Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 391-400 of 409 for breast cancer

Edit search filters
  1. Changes In GI Inflammation And The GI Microbiome Profile In Women With Breast Cancer Throughout Chemotherapy

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Learn More About Experiences Of Patients With Genetic Risk For Breast Cancer

    Jacksonville, FL

  3. Assessing Vitamin D And Mammogram Density As Biomarkers Of Breast Cancer In Olmsted County

    Rochester, MN

  4. Efficacy And Safety Of Treatment With Alpelisib Plus Endocrine Therapy In Patients With HR+, HER2-negative ABC, With PIK3CA Mutations, Whose Disease Has Progressed On Or After CDK 4/6 Treatment With An Aromatase Inhibitor (AI) Or Fulvestrant

    Scottsdale/Phoenix, AZ

  5. Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

    Jacksonville, FL

  6. A Study To Develop A Biorepository Of Blood Samples From Cancer Patients Participating In The Gemini (IRB 19-006717) Protocol

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  7. Breast Cancer Biomarker Sample Collection For The DtectDx V2 Assay Proof Of Concept Protocol

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors

    Rochester, MN

  9. A Study Of Women Having Screening Mammography At Mayo Clinic To Develop A Better Way To Predict Risks For Cancer

    Rochester, MN

  10. Characterization Of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using The CTC-Endocrine Therapy Index

    Rochester, MN

.

Mayo Clinic Footer